Florida Cancer Specialists Expands Team with New Oncologists for Better Patient Care

Enhancing Cancer Care in South Florida

In a significant move towards improving cancer treatment access, Florida Cancer Specialists & Research Institute (FCS) has announced the addition of two new medical oncologists and hematologists—Dr. Thanuja Neerukonda and Dr. Jaskirat S. Sethi. This expansion aims to deliver comprehensive, personalized oncology services to patients throughout South Florida, further solidifying FCS's reputation as a leader in the field.

Expanding Access to Care

Dr. Neerukonda is set to provide her expertise at FCS West Palm Beach and FCS Wellington North, while Dr. Sethi will serve patients at FCS Bonita Springs and FCS Estero. Their involvement is expected to enhance patient care significantly by reducing wait times and increasing the availability of specialized support for individuals battling cancer and blood disorders.

David Wenk, MD, assistant managing physician at FCS, expressed enthusiasm about Dr. Neerukonda's arrival, praising her strong commitment to personalized cancer care and her dedication to advancing treatment options. He noted, "Her expertise will help us continue providing high-quality oncology and hematology services to patients throughout Palm Beach County."

Dr. Neerukonda earned her medical degree from the University of Missouri-Kansas City School of Medicine and completed her residency in internal medicine at HCA Brandon Hospital. She further advanced her training with a fellowship in hematology and oncology at the University of Toledo Medical Center. Her clinical focus encompasses a broad range of cancers and blood disorders, providing individualized treatment plans that leverage cutting-edge medical advancements.

Commitment to Compassionate Care

Dr. Sethi comes with a similar commitment to personalized patient care. Having earned his medical degree from the University of Alabama, he completed his residency at the University of Mississippi Medical Center and followed this with a fellowship at the University of Arkansas for Medical Sciences. His passion for guiding patients through their treatment journey, ensuring they feel informed and supported, aligns perfectly with the mission of Florida Cancer Specialists. Ryan Ciarrocchi, CEO of FCS stated, "Dr. Sethi brings a strong commitment to personalized, compassionate care and a dedication to helping patients navigate their cancer treatment with confidence. We are pleased to welcome him."

A Legacy of Innovation

Florida Cancer Specialists has been at the forefront of cancer treatment for over 40 years, noted for its innovation and comprehensive care in oncology. The institute is not only committed to patient care but also actively engages in clinical research, offering numerous clinical trials that provide patients with access to the latest therapies available. Every year, FCS conducts hundreds of clinical trials that contribute to advancements in oncology and directly elevate patient outcomes. Many FDA-approved cancer drugs have been made available to FCS patients long before their official market introduction, showcasing FCS's role in driving oncology care forward.

With the addition of Dr. Neerukonda and Dr. Sethi, Florida Cancer Specialists continues its mission of delivering state-of-the-art, personalized care to cancer patients in South Florida. The future looks bright for enhanced patient services and innovative treatment strategies tailored to meet individual needs.

For more information on Florida Cancer Specialists and their services, visit FLCancer.com.